IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 54.21 USD 0.26%
Market Cap: 686.8m USD
Have any thoughts about
IRadimed Corp?
Write Note

IRadimed Corp
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRadimed Corp
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
IRadimed Corp
NASDAQ:IRMD
Selling, General & Administrative
-$27.8m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
-14%
Becton Dickinson and Co
NYSE:BDX
Selling, General & Administrative
-$4.9B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Selling, General & Administrative
-$5.8B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Selling, General & Administrative
-$7.2B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Abbott Laboratories
NYSE:ABT
Selling, General & Administrative
-$11.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-6%
Intuitive Surgical Inc
NASDAQ:ISRG
Selling, General & Administrative
-$2.1B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
No Stocks Found

IRadimed Corp
Glance View

Market Cap
686.8m USD
Industry
Health Care

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

IRMD Intrinsic Value
40.87 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is IRadimed Corp's Selling, General & Administrative?
Selling, General & Administrative
-27.8m USD

Based on the financial report for Sep 30, 2024, IRadimed Corp's Selling, General & Administrative amounts to -27.8m USD.

What is IRadimed Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-14%

Over the last year, the Selling, General & Administrative growth was -7%. The average annual Selling, General & Administrative growth rates for IRadimed Corp have been -12% over the past three years , -9% over the past five years , and -14% over the past ten years .

Back to Top